文献速递间质性肺疾病肺栓塞与肺血管病

以特发性肺纤维化起病的自身免疫性疾病相关性间质性肺疾病临床分析

[Clinical analysis of autoimmune diseases associated with interstitial lung diseases initially presented with idiopathic pulmonary fibrosis].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2022-01-01

回顾性分析北京协和医院2016年1月至2021年12月以IPF起病的14例AID-ILD患者,男13例女1例,年龄69.7±9.1岁。随访中出现气短加重、发热、镜下血尿、关节症状等表现后确诊AID,13例加用激素和(或)免疫抑制剂后好转或稳定。提示IPF患者出现上述表现需警惕AID-ILD。

要点

  • IPF随访中出现发热、镜下血尿或关节炎表现需警惕AID-ILD。
  • 14例中MPO-ANCA阳性6例、PR3-ANCA阳性1例、抗CCP阳性7例。
  • 确诊AID-ILD后加用激素和(或)免疫抑制剂,13例好转或稳定。

核心结论

  • IPF患者出现发热、镜下血尿及关节炎相关表现时需警惕AID-ILD,尤其是ANCA-UIP、AAV-UIP或RA-UIP。
  • 加用激素和(或)免疫抑制剂可能使这类患者获益。

研究设计与样本

  • 回顾性纳入2016年1月至2021年12月北京协和医院以IPF起病的AID-ILD患者14例。
  • 14例中男13例、女1例,年龄55~87(69.7±9.1)岁。

主要发现

  • 随访中出现气短加重7例、发热6例、镜下血尿5例、关节肿痛4例、关节痛2例、晨僵2例、肾功能不全2例。
  • 最终MPO-ANCA阳性6例、PR3-ANCA阳性1例、抗CCP阳性7例。
  • IPF阶段7例接受抗纤维化药物,5例使用N-乙酰半胱氨酸,1例使用N-乙酰半胱氨酸后加用抗纤维化药物,1例未接受药物治疗。
  • 确诊AID-ILD后13例加用激素和(或)免疫抑制剂,治疗后13例好转或稳定,1例无显著变化。

关键数值与推荐

  • MPO-ANCA阳性6例,PR3-ANCA阳性1例,抗CCP阳性7例。
  • 确诊AID-ILD后13例加用激素和(或)免疫抑制剂。

临床怎么用

  • IPF随访中应关注发热、镜下血尿、关节肿痛、晨僵及肾功能不全等肺外表现。
  • 出现上述表现时建议筛查ANCA及抗CCP等自身抗体以识别AID-ILD。
  • 确诊AID-ILD后可考虑加用激素和(或)免疫抑制剂并观察病情变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives: To describe the clinical characteristics of patients with autoimmune diseases associated interstitial lung diseases (AID-ILD) initially presented with idiopathic pulmonary fibrosis (IPF) in a tertiary Chinese hospital. Methods: We conducted a retrospective analysis of 14 patients diagnosed with AID-ILD during the IPF follow-up between January 2016 and December 2021. Among the 14 enrolled AID-ILD cases, there were 13 males and 1 female, (69.71±9.07) years old (range from 55 y to 87 y). Results: Detailed clinical consultation and further laboratory analysis were performed during the follow-up when the IPF patients showed exaggerated dyspnea (7 cases), fever of unknown causes (6 cases), microscopic hematuria (5 cases), arthralgia and swelling (4 cases), arthralgia (2 cases), morning stiffness (2 cases) and renal failure (2 cases). Finally, 6 patients showed positive MPO-ANCA, one patient showed positive PR3-ANCA and 7 patients showed positive anti-CCP. During the IPF periods, 7 patients had received antifibrotic agents and 5 patients had been prescribed with N-acetylcysteine, and 1 patient had received antifibrotic agents after N-acetylcysteine. Among them, no medication was prescribed for one IPF patient. After they were diagnosed with AID-ILD, glucocorticoids and/or immunosuppressants were added for 13 of them. Thirteen of cases improved or stable after these treatments, but one didn't show significant changes. Conclusions: AID-UIP, especially ANCA-UIP, AAV-UIP or RA-UIP should be considered when the IPF patients showed fever of unknown origin, microscopic hematuria and/or arthritis related symptoms. They might benefit from the add-on glucocorticoids and/or immunosuppressants. 目的: 总结以特发性肺纤维化(IPF)起病的自身免疫性疾病相关性间质性肺疾病(AID-ILD)患者的临床特征,提高临床医生对此类疾病的认识。 方法: 回顾性纳入2016年1月至2021年12月北京协和医院就诊的、以IPF起病的14例AID-ILD患者,分析其临床资料,其中男13例,女1例,年龄55~87(69.7±9.1)岁。总结诊疗过程以及疗效。 结果: 所有患者均在确诊IPF后规律随访,因出现以下临床表现进一步筛查发现AID:气短加重7例、发热6例,镜下血尿5例,关节肿痛4例,关节痛、晨僵、肾功能不全2例。最终诊断髓过氧化物酶抗体(MPO)-中性粒细胞胞质抗体(ANCA)阳性6例,抗蛋白酶3抗体(PR-3)-ANCA阳性1例,抗环瓜氨酸肽阳性7例。在最初诊断为IPF阶段,7例接受抗纤维化药物治疗,5例使用N-乙酰半胱氨酸,1例使用N-乙酰半胱氨酸后加用抗纤维化药物,1例患者未接受药物治疗。诊断AID-ILD后,1例继续吡非尼酮治疗,其余均加用了激素和(或)免疫抑制剂;调整治疗方案后,13例患者病情均好转或稳定。 结论: IPF患者出现发热、镜下血尿以及关节炎的相关表现时,需要警惕AID-ILD可能,尤其是ANCA相关性寻常型间质性肺炎(UIP)、ANCA相关性血管炎-UIP和类风湿关节炎相关性-UIP;加用激素和(或)免疫抑制剂治疗可能使其获益。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Chen RX, Liu XN, Shao C, et al. [Clinical analysis of autoimmune diseases associated with interstitial lung diseases initially presented with idiopathic pulmonary fibrosis]. Zhonghua Jie He He Hu Xi Za Zhi. 2022. PMID: 35927048. doi:10.3760/cma.j.cn112147-20220417-00327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。